Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Key facts

Sponsor

International Vaccine Institute

Principal Investigator

Dong Baiqing, MD

Guangxi Center for Disease Control and Prevention

Intervention

Typhoid Vi vaccine(biological)

Enrollment

96468 enrolled

Eligibility

5-60 years · All sexes

Timeline

2001 – 2006

Study locations (1)

• Hechi City Center for Disease Control, Hechi, Guangxi, China

Collaborators

Centers for Disease Control and Prevention · Hechi City Center for Disease Centrol · Wellcome Trust · University of Western Ontario, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Paratyphoid fever

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE4NCT07314281
  Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
  Indus Hospital and Health Network
• RECRUITINGNCT04878549
  Transcriptomic Responses for the Identification of Pathogens
  University of Sheffield

See all trials for Paratyphoid fever →